Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg
$ 25.00 · 4.6 (316) · In stock
The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.
Metro makes formal $4.5B cash and stock offer for Jean Coutu - BNN Bloomberg
How Not to Negotiate a $6.1 Billion Deal - Bloomberg
US wholesale prices picked up in February in sign that inflation pressures remain elevated, SiouxlandProud, Sioux City, IA
Home Depot Sales Drop for Fifth Straight Quarter on Weak Demand - BNN Bloomberg
Jean Coutu Q1 revenue up, profit down on Pro Doc brand - BNN Bloomberg
How Not to Negotiate a $6.1 Billion Deal - Bloomberg
Jean Coutu profits up despite generics
Where Bits and Bytes Meet Brick-and-Mortar Retail
BNN's Daily Chase: NHL playoffs boost Canada's economy; Clark's government toppled in B.C. - BNN Bloomberg
QSR) Burger King Owner's Fourth-Quarter Sales Outpace Expectations - Bloomberg
Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer - BNN Bloomberg
Mulling Over Margin, Part 1: Introduction and Historical Background - farmdoc daily
Grocers brace for generic drug deal; Loblaw stock downgraded by Desjardins - BNN Bloomberg